Literature DB >> 23576524

New method for purifying histidine-rich glycoprotein from human plasma redefines its functional properties.

Kruti K Patel1, Ivan K H Poon, Gert H Talbo, Matthew A Perugini, Nicole L Taylor, Troy J Ralph, Nicholas J Hoogenraad, Mark D Hulett.   

Abstract

Histidine-rich glycoprotein (HRG) is a relatively abundant plasma protein that has been implicated in multiple biological processes including immunity, tumor progression, and vascular biology. However, current protocols for purifying HRG from plasma result in the copurification of contaminating proteins and raise questions over the validity of biological activities ascribed to HRG. In this study, we describe a two-step protocol for the large-scale purification of HRG from human plasma using a combination of metal affinity and ion exchange chromatography. The protocol employs a rapid and simple strategy to isolate highly purified HRG that minimizes proteolytic cleavage of the protein. The purification of HRG was assessed at each stage by measuring the amount of HRG immunoreactive protein using a specific monoclonal antibody against total protein, and demonstrated ~1,000-fold purification with an overall yield of ~32%. Mass spectrometry analysis demonstrated that plasma-derived HRG was free of contaminating proteins and gel electrophoresis showed it to have minimal proteolytic degradation. Characterization of protein by physical method showed that the protein exists as a single, monodisperse species. In contrast to the previous studies of HRG purified by different methods, HRG purified using the new procedure demonstrated a reduced profile of functions. Although the HRG retained binding to heparin and phosphatidic acid, it did not interact with necrotic cells or other cellular lipids. These data demonstrate that HRG does not exhibit the broad interactive properties that have been reported previously, suggesting that copurification of HRG-binding partners or other impurities are responsible for some of the reported functional properties. The findings in this study demonstrate that the new purification procedure can provide a ready source of pure HRG to assess ligand specificity and biological function of this important plasma protein.
Copyright © 2013 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  histidine-rich glycoprotein (HRG); metal affinity chromatography; phosphatidic acid; plasma protein; protein purification

Mesh:

Substances:

Year:  2013        PMID: 23576524     DOI: 10.1002/iub.1168

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  5 in total

Review 1.  The phospholipid code: a key component of dying cell recognition, tumor progression and host-microbe interactions.

Authors:  A A Baxter; M D Hulett; I K H Poon
Journal:  Cell Death Differ       Date:  2015-10-09       Impact factor: 15.828

2.  Purification of rabbit serum histidine-proline-rich glycoprotein via preparative gel electrophoresis and characterization of its glycosylation patterns.

Authors:  Anna Katharina Weyrauch; Mario Jakob; Angelika Schierhorn; Ralf Bernd Klösgen; Dariush Hinderberger
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

Review 3.  Functional Regulation of the Plasma Protein Histidine-Rich Glycoprotein by Zn2+ in Settings of Tissue Injury.

Authors:  Kristin M Priebatsch; Marc Kvansakul; Ivan K H Poon; Mark D Hulett
Journal:  Biomolecules       Date:  2017-03-02

4.  Host Response of Atlantic Salmon (Salmo salar) Re-Inoculated with Paramoeba perurans.

Authors:  Michelle McCormack; Anita Talbot; Eugene Dillon; Ian O'Connor; Eugene MacCarthy
Journal:  Microorganisms       Date:  2021-05-05

5.  Phosphoinositide-mediated oligomerization of a defensin induces cell lysis.

Authors:  Ivan Kh Poon; Amy A Baxter; Fung T Lay; Grant D Mills; Christopher G Adda; Jennifer Ae Payne; Thanh Kha Phan; Gemma F Ryan; Julie A White; Prem K Veneer; Nicole L van der Weerden; Marilyn A Anderson; Marc Kvansakul; Mark D Hulett
Journal:  Elife       Date:  2014-04-01       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.